Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Adult (1)
- Aneurysm development (1)
- Angiotensin II (1)
- Animals (1)
- Anti-hyperlipidemia (1)
-
- Aortic Aneurysm (1)
- Atherosclerosis (1)
- Biomarkers (1)
- Cardiovascular disease (1)
- Chromatography, High Pressure Liquid (1)
- Cross-gestational (1)
- Disease Models, Animal (1)
- Early prediction (1)
- Female (1)
- First trimester (1)
- Heparin binding EGF-like growth factor (1)
- Heparin-binding EGF-like Growth Factor (1)
- Humans (1)
- Hyperlipidemias (1)
- Liver (1)
- Male (1)
- Mice (1)
- Normotensive control (1)
- Pre-Eclampsia (1)
- Preeclampsia (1)
- Pregnancy (1)
- Pregnancy Trimester, First (1)
- Receptors, LDL (1)
- Spectrometry, Mass, Electrospray Ionization (1)
- Sphingolipids (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Targeting Hepatic Heparin-Binding Egf-Like Growth Factor (Hb-Egf) Induces Anti-Hyperlipidemia Leading To Reduction Of Angiotensin Ii-Induced Aneurysm Development, Seonwook Kim, Lihua Yang, Seongu Kim, Richard G. Lee, Mark J. Graham, Judith A. Berliner, Aldons J. Lusis, Lei Cai, Ryan E. Temel, Debra L. Rateri, Sangderk Lee
Targeting Hepatic Heparin-Binding Egf-Like Growth Factor (Hb-Egf) Induces Anti-Hyperlipidemia Leading To Reduction Of Angiotensin Ii-Induced Aneurysm Development, Seonwook Kim, Lihua Yang, Seongu Kim, Richard G. Lee, Mark J. Graham, Judith A. Berliner, Aldons J. Lusis, Lei Cai, Ryan E. Temel, Debra L. Rateri, Sangderk Lee
Saha Cardiovascular Research Center Faculty Publications
Objective
The upregulated expression of heparin binding EGF-like growth factor (HB-EGF) in the vessel and circulation is associated with risk of cardiovascular disease. In this study, we tested the effects of HB-EGF targeting using HB-EGF-specific antisense oligonucleotide (ASO) on the development of aortic aneurysm in a mouse aneurysm model.
Approach and results
Low-density lipoprotein receptor (LDLR) deficient mice (male, 16 weeks of age) were injected with control and HB-EGF ASOs for 10 weeks. To induce aneurysm, the mice were fed a high fat diet (22% fat, 0.2% cholesterol; w/w) at 5 week point of ASO administration and infused with angiotensin …
Plasma Cross-Gestational Sphingolipidomic Analyses Reveal Potential First Trimester Biomarkers Of Preeclampsia, Aneta Dobierzewska, Sony Soman, Sebastian E Illanes, Andrew J. Morris
Plasma Cross-Gestational Sphingolipidomic Analyses Reveal Potential First Trimester Biomarkers Of Preeclampsia, Aneta Dobierzewska, Sony Soman, Sebastian E Illanes, Andrew J. Morris
Saha Cardiovascular Research Center Faculty Publications
Introduction
Preeclampsia (PE) is a gestational disorder, manifested in the second half of pregnancy by maternal hypertension, proteinuria and generalized edema. PE is a major cause of maternal and fetal morbidity and mortality, accounting for nearly 40% of all premature births worldwide. Bioactive sphingolipids are emerging as key molecules involved in etiopathogenesis of PE, characterized by maternal angiogenic imbalance and symptoms of metabolic syndrome. The aim of this study was to compare the cross-gestational profile of circulating bioactive sphingolipids in maternal plasma from preeclamptic (PE) versus normotensive control (CTL) subjects with the goal of identifying sphingolipids as candidate first trimester …